Literature DB >> 15177230

The impact of endovascular treatment on in-hospital mortality following non-ruptured AAA repair over a decade: a population based study of 16,446 patients.

G J M Akkersdijk1, M Prinssen, J D Blankensteijn.   

Abstract

OBJECTIVES: We hypothesised that over the past decade, the nation-wide outcome of infrarenal abdominal aortic aneurysm (AAA) repair has improved with the introduction of endovascular treatment. The aim of the study was to identify endovascularly-treated patients in a national registry and to assess the impact on in-hospital mortality of non-ruptured AAA repair, if any, after the introduction of endovascular repair.
MATERIALS AND METHODS: We retrospectively studied the nation-wide outcome of non-ruptured AAA repair over the past decade. Variables studied were age and gender of the patients, hospital size and type and the year in which treatment was performed and the outcome on in-hospital mortality. The in-hospital mortality of non-ruptured AAA repair in 16,446 patients in the 10-year period from 1991 to 2000 was 7.3% (6.2-8.2%). In the 15,589 (95%) patients that underwent conventional treatment, in-hospital mortality was 7.6% (7.0-8.1%), whereas in the endovascular group it was 1.9% (0.6-3.5%). In the multivariate analysis, age and endovascular repair were the most important independent predictors of in-hospital mortality.
CONCLUSION: With the limitations of a national registry aside, the introduction of endovascular aneurysm repair seems to have had a small but significant impact on in-hospital mortality following infrarenal AAA repair.

Entities:  

Mesh:

Year:  2004        PMID: 15177230     DOI: 10.1016/j.ejvs.2004.01.003

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  3 in total

1.  National outcomes for the treatment of ruptured abdominal aortic aneurysm: comparison of open versus endovascular repairs.

Authors:  Natalia Egorova; Jeannine Giacovelli; Giampaolo Greco; Annetine Gelijns; Craig K Kent; James F McKinsey
Journal:  J Vasc Surg       Date:  2008-11       Impact factor: 4.268

2.  Institutional Impact of EVAR's Incorporation in the Treatment of Abdominal Aortic Aneurysm: a 12 Years' Experience Analysis.

Authors:  Rui Machado; Inês Lopes Antunes; Pedro Oliveira; Carlos Pereira; Rui de Almeida
Journal:  Braz J Cardiovasc Surg       Date:  2016-04

Review 3.  Effects of study design and trends for EVAR versus OSR.

Authors:  Robert Hopkins; James Bowen; Kaitryn Campbell; Gord Blackhouse; Guy De Rose; Teresa Novick; Daria O'Reilly; Ron Goeree; Jean-Eric Tarride
Journal:  Vasc Health Risk Manag       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.